Oculis Holding AG (OCS) Amortizatization of Intangibles (2022 - 2024)
Oculis Holding AG (OCS) recorded quarterly Amortizatization of Intangibles of $50410.0 in Q1 2024, down 0.63% quarter-over-quarter from $50731.0 in Q4 2023, and up 66.52% on a YoY basis from $30272.6 in Q2 2023.
Oculis Holding AG (OCS) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Oculis Holding AG's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $50410.0 for Q1 2024.
- In Q1 2024, Amortizatization of Intangibles rose 66.52% year-over-year to $50410.0; the TTM figure through Mar 2024 stood at $201003.6 (changed N/A YoY), while the FY2023 annual figure was $182631.4, up 5.35% from the prior year.
- Amortizatization of Intangibles was $50410.0 for Q1 2024 at Oculis Holding AG, down from $50731.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $50731.0 in Q4 2023 to a low of $30272.6 in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $45629.0 across 3 years, with a median of $49814.7 in 2023.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles grew 11.07% in 2023, then soared 66.52% in 2024.
- A 3-year view of Amortizatization of Intangibles shows it stood at $45673.0 in 2022, then climbed by 11.07% to $50731.0 in 2023, then slipped by 0.63% to $50410.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $50410.0 (Q1 2024), $50731.0 (Q4 2023), and $49814.7 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 50,410.02 |
| Mar 31, 2024 | 50,410.02 |
| Dec 31, 2023 | 50,730.95 |
| Dec 31, 2023 | 50,730.95 |
| Sep 30, 2023 | 49,814.71 |
| Sep 30, 2023 | 49,814.71 |
| Jun 30, 2023 | 50,047.90 |
| Jun 30, 2023 | 50,047.90 |
| Mar 31, 2023 | 30,272.55 |
| Mar 31, 2023 | 30,272.55 |
| Dec 31, 2022 | 45,672.96 |
| Dec 31, 2022 | 45,672.96 |
| Sep 30, 2022 | 42,453.72 |
| Sep 30, 2022 | 42,453.72 |